An EORTC pilot study of filgrastim (recombinant human granulocyte colony stimulating factor) as support to a high dose-intensive epiadriamycin-cyclophosphamide regimen in chemotherapy-naive patients with locally advanced or metastatic breast cancer-Reference-Cited by-同舟云学术

An EORTC pilot study of filgrastim (recombinant human granulocyte colony stimulating factor) as support to a high dose-intensive epiadriamycin-cyclophosphamide regimen in chemotherapy-naive patients with locally advanced or metastatic breast cancer

Published:1995-09 Issue:7 Volume:6 Page:673-677
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Piccart M.J.,Bruning P.,Wildiers J.,Awada A.,Schornagel J.H.,Thomas J.,Tomiak E.,Bartholomeus S.,Witteveen P.O.,Paridaens R.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/6/7/673/373672/6-7-673.pdf

Reference6 articles.

1. Breast Disease;Harris,1991

2. The importance of dose intensity in chemotherapy of metastatic breast cancer;Hryniuk;J Clin Oncol,1984

3. Investigator’s brochure on recombinant granulocyte colony stimulating factor (r-metHuG-CSF). Amgen, Thousand Oaks, California, January 1988.

4. Granulocyte-mecro-phage colony-stimulating factor (GM-CSF) allows acceleration and dose intensity increase of CEF chemotherapy: A randomized study in patients with advanced breast cancer;Ardizzoni;Br J Cancer,1994

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Individually tailored toxicity-based 5-fluorouracil, epirubicin and cyclophosphamide (FEC) therapy of metastatic breast cancer;Acta Oncologica;2007-01

2. Final Results of a Randomized Phase III Trial Comparing Cyclophosphamide, Epirubicin, and Fluorouracil With a Dose-Intensified Epirubicin and Cyclophosphamide + Filgrastim as Neoadjuvant Treatment in Locally Advanced Breast Cancer: An EORTC-NCIC-SAKK Multicenter Study;Journal of Clinical Oncology;2003-03-01

3. Chemotherapy of Metastatic Breast Cancer: Is more better?;Breast Cancer Research and Treatment;2003-03

4. Measuring the clinical response. What does it mean?;European Journal of Cancer;2002-09

5. A randomised phase II study of conventional versus accelerated infusional chemotherapy with granulocyte colony-stimulating factor support in advanced breast cancer;Annals of Oncology;2002-06